Immunological Pathogenesis and Treatment in Acute Medicine and Critical Care
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 8920
Special Issue Editors
Interests: anesthesiology; emergency medicine; intensive care; COVID-19
Special Issues, Collections and Topics in MDPI journals
Interests: anesthesia; critical care; internal medicine; emergency medicine
Special Issues, Collections and Topics in MDPI journals
Interests: ED management; triage; hospital and ED crowding; maxi-emergency
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Acute illnesses usually affect a specific part of the body and respond to treatment. Chronic diseases often involve multiple parts of the body, do not fully respond to treatment, and symptoms persist for an extended period of time.
In the process of disease occurrence and treatment, the human immune system plays an important role. It recognizes invaders and protects the body from disease. Thus, immune system dysfunction can cause autoimmune diseases, inflammatory diseases, and cancer. Immune deficiency occurs when immune system activity falls below normal levels, leading to relapses and life-threatening infections.
This Special Issue encourages contributors to explore the relationship between acute and chronic human diseases and immunology. Understanding these mechanisms can aid in the discovery, prevention and treatment of diseases from an immunological perspective. We welcome original research papers, as well as critiques and opinion papers. Special clinical cases may also be included.
Dr. Christian Zanza
Dr. Yaroslava Longhitano
Dr. Gabriele Savioli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- acute illnesses
- chronic diseases
- immune system
- inflammation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.